UCP2 and central nervous system cancer: Without single-cell RNA sequencing (scRNA-seq) data, it is challenging to accurately identify the specific cellular subpopulations, such as glioma stem cells, malignant astrocytes, or tumor-associated macrophages, where UCP2 is highly expressed.